HYDROXYLAMINES AND DERIVATIVES FOR THE INHIBITION OF COMPLEMENT ACTIVATION

摘要

Methods for the inhibition of complement activation, for the treatment of complement-mediated pathologies, and for the treatment of drusen-mediated pathologies are disclosed. The methods utilize hydroxylamine compounds and ester derivatives thereof, administered to subjects in effective amounts.